Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA

Int J Nanomedicine. 2017 Jul 3:12:4721-4732. doi: 10.2147/IJN.S135086. eCollection 2017.

Abstract

Herein, DNA duplex was constructed through the hybridization of adenosine triphosphate (ATP)-responsive aptamer and its cDNA in which GC-rich motif could be used to load doxorubicin (DOX), and then, cationic polymer PEI25K was used as a carrier to simultaneously condense DOX-Duplex and Bcl-2 siRNA to prepare the ternary nanocomplex polyethylenimine (PEI)/DOX-Duplex/siRNA. The ATP concentration gradient between the cytosol and extracellular environment could achieve the stable loading of DOX in duplex and the rapid drug release in an ATP-responsive manner. Using human prostate tumor cell line PC-3 as a model, an obvious induction of cell proliferation could be detected with a cell viability of 53.3%, which was stronger than single cargo delivery, indicating the synergistic effect between these two components. The enhanced anti-proliferative effect of ternary nanocomplex could be attributed to the improved induction of cell apoptosis in a mitochondria-mediated pathway and cell-cycle arrest at the G2 phase. Overall, the ATP-responsive nanocarrier for co-delivering DOX and Bcl-2 siRNA has been demonstrated to be a smart delivery system with favorable anti-proliferative effect, especially for solving the multidrug resistance of tumors.

Keywords: ATP response; Bcl-2 siRNA; anti-proliferation; aptamer; doxorubicin; synergistic effect.

MeSH terms

  • Adenosine Triphosphate / metabolism*
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Doxorubicin / administration & dosage*
  • Doxorubicin / pharmacology
  • Drug Delivery Systems / methods*
  • Drug Liberation
  • Humans
  • Male
  • Nanoparticles / administration & dosage
  • Polyethyleneimine / chemistry
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / pathology
  • Proto-Oncogene Proteins c-bcl-2 / genetics*
  • RNA, Small Interfering / administration & dosage*
  • RNA, Small Interfering / genetics

Substances

  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Small Interfering
  • Doxorubicin
  • Adenosine Triphosphate
  • Polyethyleneimine